Connect with a Growing Community of Preclinical & Translational Oncology Industry Experts from Across the UK & Western Europe
The exploration of new targets and modalities in Europe continues, new models undergo validation, and global regulators push for more non-animal model data. With all these changes, 2025 is a critical year for biopharma to identify the right partners to support them de-risking their candidate’s journey to the clinic.
The 14th Tumour Models Summit London returns to unite 130+ preclinical and translational oncology experts from biopharma keen to implement more translatable oncology models to advance clinical translation.
As the longest-standing industry preclinical oncology modelling meeting currently working with the likes of LabCorp, genOway, Champions Oncology and more, can we help you elevate your brand within this dynamic market?
What to Expect?
Meet New Clients
Expand your client base within the oncology community by networking face-to-face with dedicated senior attendees actively seeking solutions to overcome their preclinical and translational modelling challenges.
Centre Yourself in Biopharma Dealmaking
Position your brand in front of senior decision-makers by showcasing your company logo on event materials including our website, brochure, and on-site signage.
Demonstrate Yourself as THE ‘Go-To’ Partner
Present your work through a speaking engagement and a poster, participate in a panel discussion or showcase your solutions in a bespoke exhibition booth to demonstrate your company's unique capabilities.
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from KOLs. Gain insights and competitor strategies to shape your organization’s future and sharpen its competitive edge.
Key Services & Solutions
Our audience of tumour modelling experts and senior decision makers from leading European oncology biopharma are seeking support in:
- Optimising patient-derived in vivo tumour models to empower efficacy and toxicology studies across modalities and indications
- Validating in vitro, complex in vitro, and ex vivo tumour models to advance early drug discovery through to assessing toxicity
- Linking clinically relevant biomarkers to better understand disease mechanisms and predict patients’ response to treatment with biomarker assays
- Leveraging digital pathology tools to empower model selection, improve modelling techniques, identify underserved patient populations and predict effective treatment regimes
If your expertise aligns with the above, then this meeting is an unmissable opportunity to position yourself alongside the leading voices in the field, elevate your solutions and services, and become the ‘go-to’ partner for biopharma for all things tumour modelling and preclinical oncology-related.
Hear What Our Past Sponsors Have to Say
It was a good balance of industry, academia and CROs and good to focus on oncology.
Senior BD Director, Reaction Biology
Very easy to network due to the relatively small number of attendees and the one room for meeting up.
Director - Business Development, WuXi AppTec
Audience Composition
Attendees by Country
Attendee Seniority
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Marinela Tice
Senior Partnerships Director
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.